ATE369847T1 - Aminoguanidine zur behandlung von diabetes typ ii - Google Patents

Aminoguanidine zur behandlung von diabetes typ ii

Info

Publication number
ATE369847T1
ATE369847T1 AT96944681T AT96944681T ATE369847T1 AT E369847 T1 ATE369847 T1 AT E369847T1 AT 96944681 T AT96944681 T AT 96944681T AT 96944681 T AT96944681 T AT 96944681T AT E369847 T1 ATE369847 T1 AT E369847T1
Authority
AT
Austria
Prior art keywords
diabetes
type
treatment
aminoguanidine
human
Prior art date
Application number
AT96944681T
Other languages
English (en)
Inventor
Nicholas Turner
Valerie Piercy
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9526330.7A external-priority patent/GB9526330D0/en
Priority claimed from GBGB9624914.9A external-priority patent/GB9624914D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE369847T1 publication Critical patent/ATE369847T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Processing Of Solid Wastes (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT96944681T 1995-12-22 1996-12-18 Aminoguanidine zur behandlung von diabetes typ ii ATE369847T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9526330.7A GB9526330D0 (en) 1995-12-22 1995-12-22 Novel method
GBGB9624914.9A GB9624914D0 (en) 1996-11-29 1996-11-29 Novel method

Publications (1)

Publication Number Publication Date
ATE369847T1 true ATE369847T1 (de) 2007-09-15

Family

ID=26308373

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96944681T ATE369847T1 (de) 1995-12-22 1996-12-18 Aminoguanidine zur behandlung von diabetes typ ii

Country Status (18)

Country Link
EP (1) EP0868176B1 (de)
JP (1) JP2000502667A (de)
KR (1) KR19990076594A (de)
CN (1) CN1209058A (de)
AT (1) ATE369847T1 (de)
AU (1) AU1307697A (de)
BR (1) BR9612250A (de)
CA (1) CA2240492A1 (de)
CZ (1) CZ198798A3 (de)
DE (1) DE69637209T2 (de)
ES (1) ES2292176T3 (de)
HU (1) HUP9903978A3 (de)
IL (1) IL124869A0 (de)
MX (1) MX9805099A (de)
NO (1) NO982853D0 (de)
PL (1) PL327471A1 (de)
TR (1) TR199801120T2 (de)
WO (1) WO1997023203A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20020625A1 (it) * 2002-12-17 2004-06-18 Sigma Tau Ind Farmaceuti Derivati di guanidine variamente sostituite, loro uso come medicamenti ad attivita' antidiabetica e/o antiobesita'.
CN100411615C (zh) * 2003-12-12 2008-08-20 上海第二医科大学附属瑞金医院 氨基胍对难愈创面的防治作用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665192A (en) * 1984-03-19 1987-05-12 The Rockefeller University 2-(2-furoyl)-4(5)-2(furanyl)-1H-imidazole
AU7316591A (en) * 1990-02-28 1991-09-18 Upjohn Company, The Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
AU3876995A (en) * 1994-11-17 1996-06-17 McDougall, Greg Electric fan heater

Also Published As

Publication number Publication date
EP0868176B1 (de) 2007-08-15
EP0868176A1 (de) 1998-10-07
BR9612250A (pt) 1999-07-13
KR19990076594A (ko) 1999-10-15
HUP9903978A2 (hu) 2000-03-28
HUP9903978A3 (en) 2001-01-29
MX9805099A (es) 1998-10-31
CN1209058A (zh) 1999-02-24
PL327471A1 (en) 1998-12-07
DE69637209D1 (de) 2007-09-27
ES2292176T3 (es) 2008-03-01
JP2000502667A (ja) 2000-03-07
WO1997023203A1 (en) 1997-07-03
CA2240492A1 (en) 1997-07-03
NO982853L (no) 1998-06-19
CZ198798A3 (cs) 1999-06-16
DE69637209T2 (de) 2008-05-08
TR199801120T2 (xx) 1998-09-21
AU1307697A (en) 1997-07-17
NO982853D0 (no) 1998-06-19
IL124869A0 (en) 1999-01-26

Similar Documents

Publication Publication Date Title
DK0755249T3 (da) Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom
NO982311L (no) Sammensetninger og fremgangsmÕter for forhindring og behandling av oral muscositt
ATE207342T1 (de) Gegen hautalterung wirksame stoffe oder wirkstoffkombinationen und zubereitungen
ATE461698T1 (de) Gaba-analoga zur verhütung und behandlung gastrointestinaler beschwerden
NO962162D0 (no) Dipeptider som bevirker frigjöring av veksthormon
DK1039894T3 (da) Præparater til at forøge koncentrationen og/eller bevægeligheden af spermatozoer hos mennesker
ATE369847T1 (de) Aminoguanidine zur behandlung von diabetes typ ii
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
ATE182781T1 (de) Lutschbonbon mit zahnbelags-neutralisierender wirkung
DK0722325T3 (da) Præparat til behandling eller forebyggelse af herpes
DE69626307T2 (de) Inhibitor von stickstoffmonoxid (no) synthase zur verhütung von typ ii diabetes
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATE235249T1 (de) Die von morphogenen peptiden hervorgerufene wiederherstellung von gewebe aus sinneszellen
MD682F1 (en) Agent for fruits and grapes treatment under the storage
ATE321551T1 (de) Methoden zur behandlung des kryptorchysmus
TH68A3 (th) การรักษาสีเปลือกผลลิ้นจี่

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties